Kiley Juergens Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-379
Closed -$133K – 102
2018
Q3
$133K Buy
379
+40
+12% +$13.8K 0.1% 132
2018
Q2
$98K Buy
+339
New +$95.3K 0.09% 134
2018
Q1
– Sell
-339
Closed -$107K – 139
2017
Q4
$107K Buy
+339
New +$109K 0.1% 119

Other funds holding BIIB

Kiley Juergens Wealth Management's BIIB Position: Q4 2018 in Review

Kiley Juergens Wealth Management sold out of Biogen (BIIB) in Q4 2018, closing a stake of 379 shares — an estimated $133K sold.

Kiley Juergens Wealth Management first reported a position in BIIB in Q4 2017 and held it in 3 quarters. The position peaked at $133K in Q3 2018. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Kiley Juergens Wealth Management reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Kiley Juergens Wealth Management sold 379 Biogen shares in Q4 2018, an estimated $133K.
  • Kiley Juergens Wealth Management first reported a position in Biogen in Q4 2017 and held it in 3 quarters.
  • Kiley Juergens Wealth Management's Biogen position peaked at $133K in Q3 2018.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Kiley Juergens Wealth Management's 13F filing for Q4 2018, filed 15 Jan 2019.